Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

DVA

Delivra (DVA)

Delivra Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSXV:DVA
DataHoraFonteTítuloCódigoCompanhia
03/07/201911:27PR Newswire (Canada)Harvest One Completes Acquisition of DelivraTSXV:DVADelivra Corp
28/06/201918:00PR Newswire (Canada)Harvest One and Delivra Provide Update on Closing Date of TransactionTSXV:DVADelivra Corp
30/05/201922:00PR Newswire (Canada)Delivra Announces Q1 2019 ResultsTSXV:DVADelivra Corp
28/05/201908:00PR Newswire (Canada)Delivra Corp. Announces Shareholder Approval of Plan of ArrangementTSXV:DVADelivra Corp
11/04/201908:00PR Newswire (Canada)Delivra Announces Record Sales For 2018TSXV:DVADelivra Corp
04/03/201911:08PR Newswire (Canada)Harvest One Acquires Delivra to Strengthen its Medical and Wellness DivisionTSXV:DVADelivra Corp
04/03/201911:06PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - DVATSXV:DVADelivra Corp
04/03/201911:04PR Newswire (Canada)IIROC Trading Resumption - DVATSXV:DVADelivra Corp
04/03/201910:37PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - DVATSXV:DVADelivra Corp
04/03/201910:34PR Newswire (Canada)IIROC Trading Halt - DVATSXV:DVADelivra Corp
06/02/201910:00PR Newswire (Canada)Delivra Publishes Positive Results Utilizing its Unique Platform Technology for Topical DoxycyclineTSXV:DVADelivra Corp
08/01/201910:00PR Newswire (Canada)Delivra publishes positive results utilizing its novel platform technology for Varicose VeinsTSXV:DVADelivra Corp
11/12/201810:00PR Newswire (Canada)Delivra publishes positive results using its platform technology for topical Advil™ (ibuprofen) and Celebrex™ (celecoxib)TSXV:DVADelivra Corp
27/11/201815:43PR Newswire (Canada)View from the C-Suite: Dr. Joseph Gabriele, Chief Executive Officer, Delivra Corp., tells his company's story. Filmed on Nove...TSXV:DVADelivra Corp
19/11/201810:00PR Newswire (Canada)Delivra Achieves Record Third Quarter 2018 RevenuesTSXV:DVADelivra Corp
30/10/201808:00PR Newswire (Canada)Ernst & Young Names Dr. Joseph Gabriele of Delivra - Entrepreneur of the Year 2018 Ontario Award in the Health Care CategoryTSXV:DVADelivra Corp
15/10/201808:00PR Newswire (Canada)Delivra Announces Stock Option Grant and Postponement of Warrant ExpiryTSXV:DVADelivra Corp
01/10/201808:00PR Newswire (Canada)Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma IndustriesTSXV:DVADelivra Corp
27/08/201808:00PR Newswire (Canada)Delivra announces appointment of Chief Financial OfficerTSXV:DVADelivra Corp
20/08/201808:00PR Newswire (Canada)Delivra achieves record second quarter 2018 resultsTSXV:DVADelivra Corp
22/05/201808:00PR Newswire (Canada)Delivra Announces First Quarter Financial ResultsTSXV:DVADelivra Corp
03/05/201808:00PR Newswire (Canada)Delivra Exposes that the Cannabis Market Requires Further Standardization and Rigourous TestingTSXV:DVADelivra Corp
26/04/201808:00PR Newswire (Canada)Delivra's Successful Product Development Strategy Yields Product Line Expansions - Including Cannabis-Related ProductsTSXV:DVADelivra Corp
24/04/201808:00PR Newswire (Canada)Delivra successfully demonstrates targeted pain relief with topical ibuprofenTSXV:DVADelivra Corp
18/04/201808:00PR Newswire (Canada)Delivra Publishes Pivotal Results on the Cholesterol & Lipid Lowering Agent BerberineTSXV:DVADelivra Corp
10/04/201808:00PR Newswire (Canada)Delivra announces 20% sales growth for 2017TSXV:DVADelivra Corp
05/04/201820:09PR Newswire (Canada)Delivra Corp. Completes $1,246,498.20 Non-Brokered FinancingTSXV:DVADelivra Corp
01/02/201810:00PR Newswire (Canada)Delivra Signs Distribution Agreement With NKS Health for Ready to Market Compounded Finished Products to Medical DoctorsTSXV:DVADelivra Corp
25/01/201810:00PR Newswire (Canada)Delivra signs a joint venture with Intervivo Solutions for a ready to market sleep and anti-anxiety topical therapeutic cream...TSXV:DVADelivra Corp
16/01/201810:00PR Newswire (Canada)Delivra develops a revolutionary topical cream utilizing cannabis and opioid molecules for safer delivery in patients with ch...TSXV:DVADelivra Corp
 Apresentando as notícias mais relevantes sobre:TSXV:DVA